Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

834.04
+7.400.90%
Post-market: 834.040.00000.00%19:58 EDT
Volume:786.92K
Turnover:656.91M
Market Cap:85.87B
PE:20.63
High:847.00
Open:835.74
Low:826.64
Close:826.64
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.27
T/O Rate:0.80%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.71
PE(LYR):20.11

Loading ...

Biocon Launches Yesafili Biosimilar to Regeneron’s Eylea in US

Reuters
·
Aug 03

Weekly Winners | Microsoft Rockets 22%; Garmin Soars 21%; Amazon, Chipotle Jump 17% Each; Regeneron Pharmaceuticals Gains 16%

Tiger Newspress
·
Aug 02

Movement Alert|Regeneron Pharmaceuticals Rises 3.09% in Regular Trading, Q2 Earnings Beat Continues to Drive Stock Higher

Market Focus
·
Aug 01

Regeneron Announces Q3 2026 Distribution of R$ 0.05 Per Unit

Reuters
·
Jul 31

Regeneron Pharmaceuticals' Robust Q2 Sales Amid Limited Spend Increases to Help Ramp H2 Margins, RBC Says

MT Newswires Live
·
Jul 31

Regeneron Pharma is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Regeneron (REGN) and PTC Therapeutics (PTCT)

TIPRANKS
·
Jul 31

Regeneron price target raised to $795 from $750 at Cantor Fitzgerald

TIPRANKS
·
Jul 31

AbbVie Beats Q2 Revenue, Adjusted EPS Estimates but Cuts FY Adj EPS Guidance

Reuters
·
Jul 31

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

GlobeNewswire
·
Jul 31

Morgan Stanley Adjusts PT on Regeneron Pharmaceuticals to $758 From $730, Keeps Equalweight Rating

MT Newswires Live
·
Jul 31

Regeneron Pharmaceuticals Inc : JP Morgan Raises Target Price to $900 from $850

THOMSON REUTERS
·
Jul 31

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Stock Track | Regeneron Pharmaceuticals Soars 5.79% in Intraday Trading After Q2 Earnings Crush Estimates on Dupixent and Eylea HD Strength

Stock Track
·
Jul 31

Regeneron Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Movement Alert|Regeneron Pharmaceuticals Rises 3.19% in Regular Trading, Q2 Earnings Massively Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Shares up 1% After Upbeat Q2 Results

THOMSON REUTERS
·
Jul 30